Park K, Ozguroglu M, Vansteenkiste J, Spigel D, et al. Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial. Lung Cancer 2021;154:92-98.
PMID: 33636453